SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Cell>Point Announces Agreement with FDA on Special Protocol Assessment for Phase 3 Trial of Technetium-99m-EC-G for Imaging Lung Cancer